Nifty
Sensex
:
:
11513.90
39052.06
49.90 (0.44%)
453.07 (1.17%)

Pharmaceuticals & Drugs

Rating :
28/99

BSE: 532660 | NSE: VIVIMEDLAB

13.25
17-Oct-2019
  • Open
  • High
  • Low
  • Previous Close
  •  13.45
  •  13.50
  •  13.00
  •  13.25
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  57363
  •  7.61
  •  43.80
  •  12.60

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 109.86
  • 2.80
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 969.27
  • N/A
  • 0.19

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 34.23%
  • 6.92%
  • 34.08%
  • FII
  • DII
  • Others
  • 1.07%
  • 0.12%
  • 23.58%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 14.37
  • -0.96
  • -3.46

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 10.13
  • -5.31
  • -16.02

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.35
  • -4.45
  • -35.52

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 5.90
  • 6.07
  • 4.04

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.03
  • 0.94
  • 0.79

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 5.70
  • 5.61
  • 5.07

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 19
Jun 18
Var%
Mar 19
Mar 18
Var%
Dec 18
Dec 17
Var%
Sep 18
Sep 17
Var%
Net Sales
344.21
358.54
-4.00%
348.08
285.61
21.87%
243.93
299.58
-18.58%
364.62
282.50
29.07%
Expenses
303.11
289.74
4.61%
326.69
251.87
29.71%
207.18
250.68
-17.35%
314.42
219.90
42.98%
EBITDA
41.10
68.80
-40.26%
21.39
33.74
-36.60%
36.74
48.89
-24.85%
50.20
62.60
-19.81%
EBIDTM
11.94%
19.19%
6.14%
11.82%
15.06%
16.32%
13.77%
22.16%
Other Income
1.27
5.75
-77.91%
6.10
2.87
112.54%
6.31
3.12
102.24%
5.04
0.61
726.23%
Interest
12.11
19.28
-37.19%
12.83
16.37
-21.62%
17.56
17.18
2.21%
17.59
21.36
-17.65%
Depreciation
16.95
15.87
6.81%
16.05
13.84
15.97%
15.29
13.94
9.68%
19.58
16.09
21.69%
PBT
13.31
39.40
-66.22%
-1.40
6.41
-
10.21
20.89
-51.12%
18.07
25.78
-29.91%
Tax
3.16
10.95
-71.14%
-1.41
-2.50
-
-0.63
-0.03
-
-0.21
3.71
-
PAT
10.15
28.46
-64.34%
0.01
8.91
-99.89%
10.84
20.92
-48.18%
18.28
22.07
-17.17%
PATM
2.95%
7.94%
0.00%
3.12%
4.44%
6.98%
5.01%
7.81%
EPS
1.22
3.45
-64.64%
0.00
1.30
-100.00%
1.31
2.53
-48.22%
2.21
2.69
-17.84%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Net Sales
1,300.84
1,315.17
1,185.66
1,461.91
1,345.63
1,380.10
1,350.83
1,108.80
668.31
416.00
343.49
Net Sales Growth
6.08%
10.92%
-18.90%
8.64%
-2.50%
2.17%
21.83%
65.91%
60.65%
21.11%
 
Cost Of Goods Sold
533.96
518.40
479.67
536.28
624.05
646.23
656.33
513.27
337.39
236.97
203.49
Gross Profit
766.88
796.77
705.99
925.63
721.58
733.88
694.51
595.52
330.93
179.03
140.00
GP Margin
58.95%
60.58%
59.54%
63.32%
53.62%
53.18%
51.41%
53.71%
49.52%
43.04%
40.76%
Total Expenditure
1,151.40
1,146.24
970.79
1,057.46
1,122.68
1,158.21
1,166.29
928.00
538.02
329.44
279.13
Power & Fuel Cost
-
42.77
34.73
34.78
38.26
46.70
51.39
44.06
22.33
11.08
8.28
% Of Sales
-
3.25%
2.93%
2.38%
2.84%
3.38%
3.80%
3.97%
3.34%
2.66%
2.41%
Employee Cost
-
241.76
197.78
189.98
176.94
184.43
162.66
50.33
32.19
19.97
22.07
% Of Sales
-
18.38%
16.68%
13.00%
13.15%
13.36%
12.04%
4.54%
4.82%
4.80%
6.43%
Manufacturing Exp.
-
217.39
176.69
175.06
167.31
179.26
182.37
230.50
91.61
32.06
19.82
% Of Sales
-
16.53%
14.90%
11.97%
12.43%
12.99%
13.50%
20.79%
13.71%
7.71%
5.77%
General & Admin Exp.
-
111.52
78.75
93.93
95.26
76.30
86.64
69.34
31.42
15.96
15.29
% Of Sales
-
8.48%
6.64%
6.43%
7.08%
5.53%
6.41%
6.25%
4.70%
3.84%
4.45%
Selling & Distn. Exp.
-
14.41
16.66
15.39
20.86
25.29
26.91
20.50
23.09
11.26
9.32
% Of Sales
-
1.10%
1.41%
1.05%
1.55%
1.83%
1.99%
1.85%
3.45%
2.71%
2.71%
Miscellaneous Exp.
-
0.00
-13.49
12.03
0.00
0.00
0.00
0.00
0.00
2.14
9.32
% Of Sales
-
0%
-1.14%
0.82%
0%
0%
0%
0%
0%
0.51%
0.25%
EBITDA
149.43
168.93
214.87
404.45
222.95
221.89
184.54
180.80
130.29
86.56
64.36
EBITDA Margin
11.49%
12.84%
18.12%
27.67%
16.57%
16.08%
13.66%
16.31%
19.50%
20.81%
18.74%
Other Income
18.72
33.97
9.61
8.09
23.63
8.02
35.90
26.33
2.68
1.00
6.84
Interest
60.09
70.06
82.35
67.79
85.26
86.20
67.46
50.44
28.37
22.10
22.82
Depreciation
67.87
66.79
56.42
58.28
61.39
66.18
66.12
58.81
26.79
10.20
8.73
PBT
40.19
66.05
85.71
286.48
99.93
77.54
86.86
97.88
77.82
55.26
39.65
Tax
0.91
8.68
9.62
72.50
16.26
5.49
20.47
14.29
14.68
6.43
8.63
Tax Rate
2.26%
13.14%
11.22%
25.31%
16.27%
7.08%
23.57%
14.60%
18.86%
11.64%
21.77%
PAT
39.28
57.37
77.94
213.97
83.67
72.05
66.39
83.58
63.14
48.83
31.01
PAT before Minority Interest
39.28
57.37
76.09
213.97
83.67
72.05
66.39
83.58
63.14
48.83
31.01
Minority Interest
0.00
0.00
1.85
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
3.02%
4.36%
6.57%
14.64%
6.22%
5.22%
4.91%
7.54%
9.45%
11.74%
9.03%
PAT Growth
-51.12%
-26.39%
-63.57%
155.73%
16.13%
8.53%
-20.57%
32.37%
29.31%
57.47%
 
Unadjusted EPS
4.74
6.95
9.22
26.41
51.64
44.47
40.97
52.04
45.31
48.04
31.12

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Shareholder's Funds
943.79
1,226.40
734.21
585.15
559.24
560.36
509.14
474.79
196.71
144.86
Share Capital
341.73
341.73
16.20
80.15
80.15
80.15
80.01
144.88
10.16
9.96
Total Reserves
602.07
884.67
718.01
505.00
479.09
477.84
426.77
327.54
177.68
129.94
Non-Current Liabilities
489.65
356.86
503.86
561.11
538.36
532.58
449.68
360.72
148.25
251.48
Secured Loans
369.08
275.90
396.25
206.75
436.44
378.81
255.19
258.03
131.90
234.55
Unsecured Loans
55.72
49.30
57.07
50.52
46.94
40.92
41.73
53.35
0.00
0.74
Long Term Provisions
9.21
7.03
2.19
3.57
3.17
5.16
1.47
1.06
1.69
0.00
Current Liabilities
888.93
790.23
817.39
897.41
800.86
744.42
610.73
463.69
242.44
59.38
Trade Payables
294.42
201.99
178.59
166.74
188.71
190.49
166.28
156.86
44.06
42.35
Other Current Liabilities
227.11
147.64
179.92
285.85
176.38
138.78
116.10
40.79
4.68
0.04
Short Term Borrowings
332.30
385.16
381.47
407.76
389.38
375.43
301.13
232.82
175.08
0.00
Short Term Provisions
35.10
55.43
77.41
37.06
46.39
39.71
27.22
33.21
18.61
17.00
Total Liabilities
2,322.37
2,385.77
2,055.46
2,043.67
1,898.46
1,837.36
1,569.55
1,299.20
587.40
455.72
Net Block
964.92
1,035.36
878.90
814.17
813.47
807.92
709.04
595.35
264.29
254.72
Gross Block
1,156.58
1,128.64
915.77
1,663.33
1,599.11
1,526.04
1,329.52
1,167.48
812.71
289.11
Accumulated Depreciation
191.65
93.29
36.87
849.16
785.64
718.12
620.49
572.13
548.42
34.39
Non Current Assets
1,091.77
1,103.83
961.04
911.03
906.45
846.28
736.20
604.41
266.01
255.86
Capital Work in Progress
122.31
65.27
76.13
94.17
90.28
38.12
26.92
8.37
1.73
1.14
Non Current Investment
2.51
2.70
2.71
2.69
2.70
0.24
0.24
0.70
0.00
0.00
Long Term Loans & Adv.
1.52
0.00
2.81
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Non Current Assets
0.50
0.50
0.50
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
1,230.61
1,281.94
1,094.42
1,132.60
991.96
970.90
815.08
647.14
314.68
194.06
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
563.69
540.17
483.97
490.80
431.43
426.66
340.26
247.88
84.47
79.35
Sundry Debtors
356.11
275.43
200.14
326.24
329.58
347.83
308.23
221.61
127.56
93.86
Cash & Bank
95.30
99.03
55.47
30.96
26.67
34.57
23.96
36.34
11.10
5.62
Other Current Assets
215.51
29.59
22.53
11.73
204.28
161.84
142.64
141.32
91.55
15.23
Short Term Loans & Adv.
184.76
337.73
332.31
272.88
185.21
139.50
119.82
141.09
89.45
15.20
Net Current Assets
341.68
491.71
277.03
235.19
191.10
226.47
204.35
183.45
72.25
134.67
Total Assets
2,322.38
2,385.77
2,055.46
2,043.67
1,898.45
1,837.36
1,569.55
1,299.21
587.39
455.73

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Cash From Operating Activity
422.14
21.42
57.96
154.12
140.48
-117.65
90.11
45.17
23.89
55.13
PBT
66.05
85.71
286.48
99.93
77.54
86.86
97.88
77.81
55.26
39.65
Adjustment
134.05
135.90
124.15
101.94
111.32
101.31
80.43
55.16
32.30
30.82
Changes in Working Capital
237.03
-158.14
-315.94
-47.75
-48.38
-305.83
-94.13
-87.81
-63.67
5.89
Cash after chg. in Working capital
437.13
63.48
94.69
154.12
140.48
-117.65
84.18
45.17
23.89
76.36
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-14.99
-42.06
-36.73
0.00
0.00
0.00
5.93
0.00
0.00
0.00
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-88.87
-163.53
-68.49
-190.42
-106.71
-291.11
-169.59
-424.15
-72.39
-7.13
Net Fixed Assets
-15.53
38.52
-25.51
-6.97
-49.04
-16.56
-128.68
-148.52
-26.78
7.77
Net Investments
64.34
-64.27
142.45
0.00
-2.50
-132.00
-8.38
-83.77
0.09
-0.98
Others
-137.68
-137.78
-185.43
-183.45
-55.17
-142.55
-32.53
-191.86
-45.70
-13.92
Cash from Financing Activity
-337.80
185.66
35.05
40.59
-41.67
419.37
67.10
404.22
53.98
-59.36
Net Cash Inflow / Outflow
-4.53
43.56
24.51
4.29
-7.90
10.62
-12.38
25.24
5.47
-11.35
Opening Cash & Equivalents
99.03
55.47
30.96
26.67
34.57
23.96
36.34
11.10
5.62
16.98
Closing Cash & Equivalent
94.50
99.03
55.47
30.96
26.67
34.57
23.96
36.34
11.10
5.62

Financial Ratios

Consolidated /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Book Value (Rs.)
70.35
104.60
85.93
64.20
61.00
58.36
52.74
42.03
35.45
26.71
ROA
2.44%
3.43%
10.44%
4.25%
3.86%
3.90%
5.83%
6.69%
9.36%
6.87%
ROE
7.95%
9.76%
35.18%
16.50%
14.90%
14.81%
23.34%
26.70%
31.18%
27.74%
ROCE
7.03%
9.04%
21.86%
11.93%
10.91%
11.93%
13.83%
14.29%
17.80%
16.30%
Fixed Asset Turnover
1.15
1.16
1.13
0.82
0.88
0.95
0.89
0.67
0.76
1.26
Receivable days
87.64
73.20
65.71
88.94
89.58
88.63
87.21
95.35
97.13
87.46
Inventory Days
153.18
157.64
121.69
125.08
113.47
103.61
96.80
90.76
71.87
78.89
Payable days
79.66
70.90
60.76
60.42
57.00
57.11
62.91
65.22
47.96
41.69
Cash Conversion Cycle
161.15
159.93
126.64
153.61
146.05
135.14
121.10
120.89
121.04
124.66
Total Debt/Equity
1.05
0.69
1.45
1.63
1.81
1.66
1.36
1.33
1.70
1.77
Interest Cover
1.94
2.04
5.23
2.17
1.90
2.29
2.94
3.74
3.50
2.74

News Update:


  • Vivimed Labs enters into agreements for sale of its arm
    7th Sep 2019, 16:04 PM

    The company has entered into definitive agreement for sale its arm to Vivimed Specialty Chemicals UK

    Read More
  • Vivimed Labs - Quarterly Results
    9th Aug 2019, 22:44 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.